MANTLE CELL LYMPHOMA RECURRENT

This adverse event was reported 435 times

These drugs are most commonly taken by patients reporting MANTLE CELL LYMPHOMA RECURRENT:

# Drug Count
0 RITUXIMAB 265
1 CYCLOPHOSPHAMIDE 191
2 CYCLOPHOSPHAMIDE FOR INJECTION 191
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 191
4 IBRUTINIB 169
5 DOXORUBICIN 147
6 CYTARABINE 126
7 PREDNISONE 120
8 DEXAMETHASONE 103
9 DEXAMETHASONE 1.5 MG 103
See all common drugs associated with MANTLE CELL LYMPHOMA RECURRENT

MANTLE CELL LYMPHOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAPSICUM OLEORESIN 1 0.0435
1 BREXUCABTAGENE AUTOLEUCEL 36 0.0167
2 FLUDEOXYGLUCOSE F-18 4 0.0142
3 ZANUBRUTINIB 34 0.0075
4 PIRTOBRUTINIB 7 0.0071
5 BENDAMUSTINE HYDROCHLORIDE 58 0.0068
6 CARMUSTINE 29 0.0061
7 BENDAMUSTINE HCL 56 0.0036
8 IBRITUMOMAB TIUXETAN 4 0.0026
9 TETRACAINE 1 0.0025
See all drugs enriched for association with MANTLE CELL LYMPHOMA RECURRENT